Guoxin health: to acquire equity of Yiyong technology and increase capital
Guoxin Health announced that the company plans to purchase 5.05% equity of Yiyong technology held by Shengshi Luowei in cash at a transaction price of 24.6 million yuan. After the completion of the above transfer, Guoxin health plans to invest 57.4 million yuan in cash to increase the capital of the target company. After the completion of the capital increase, the shareholding ratio of Guoxin health to the target company will reach 10.02%. Yiyong technology is a technology enterprise that carries out business around the tumor big data ecosystem.
This text is a result of machine translation.
Related companies：
Briefing Jun 27, 2022 10:35 AM
· Consumer Staples
Huayou cobalt industry: the company has entered the industry chain of global head power batteries such as Ningde times and LG Chemical
In-depth
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Jun 21, 2022 10:51 AM
· Automotive
The cumulative delivery of Xiaopeng automobile exceeded 200000 units
Briefing May 23, 2022 06:08 PM
· Automotive
Xiaopeng automobile's revenue in the first quarter of 2022 was 7.45 billion yuan
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
China’s “Dark Cuisine” and Southeast Asia’s Wealth Code
Apr 07, 2025 03:46 PM
Insight
In-depth
Insight
In-depth
